Innate Pharma Reports Third Quarter 2026 Business and Financial Update
MARSEILLE, France, November 05, 2026--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today reported its financial update for the nine months ended September 30, 2026.

What's Your Reaction?









